None of the cell-cycle control genes, including the 31 we previously showed to be associated with a high probability of prostate cancer progression [54] were modulated in their expression following knockdown or RPL19. Similarly, none of the genes recognized to mediate apoptosis were modulated in the transfectants. The gene discussed is RPL19; the disease is prostate cancer.